Prucalopride: evaluation of the pharmacokinetics, pharmacodynamics, efficacy and safety in the treatment of chronic constipation

Prucalopride for chronic intestinal pseudo-obstruction

(2012) P. Oustamanolakis et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Systematic review: cardiovascular safety profile of 5-HT4 agonists developed for gastrointestinal disorders

(2012) J. Tack et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Randomised clinical trial: the efficacy of prucalopride in patients with chronic intestinal pseudo-obstruction - a double-blind, placebo-controlled, cross-over, multiple n = 1 study

(2011) A. V. Emmanuel et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Prevalence of and Risk Factors for, Chronic Idiopathic Constipation in the Community: Systematic Review and Meta-analysis

(2011) Nicole C Suares et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Current and future therapies for chronic constipation

(2011) J. Tack   BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY

Quality of life in children and adults with constipation

(2011) Arnold Wald et al.   BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY

Assessment of the cardiac safety of prucalopride in healthy volunteers: a randomized, double-blind, placebo- and positive-controlled thorough QT study

(2011) Boaz Mendzelevski et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Impact of Chronic Constipation on Health-Related Quality of Life, Work Productivity, and Healthcare Resource Use: An Analysis of the National Health and Wellness Survey

(2011) Shawn X. Sun et al.   DIGESTIVE DISEASES AND SCIENCES

Diagnosis and treatment of chronic constipation - a European perspective

(2011) J. Tack et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Clinical trial: the efficacy of open-label prucalopride treatment in patients with chronic constipation - follow-up of patients from the pivotal studies

(2010) M. Camilleri et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Efficacy and Safety of Prucalopride in Patients with Chronic Noncancer Pain Suffering from Opioid-Induced Constipation

(2010) Cornelius E. J. Sloots et al.   DIGESTIVE DISEASES AND SCIENCES

5-HT4 receptor agonists: similar but not the same

(2010) J. H. De Maeyer et al.   NEUROGASTROENTEROLOGY AND MOTILITY

A double-blind, placebo-controlled study of prucalopride in elderly patients with chronic constipation

(2010) S. Müller-lissner et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Selective desensitization of the 5-HT4receptor-mediated response in pig atrium but not in stomach

(2009) JH De Maeyer et al.   BRITISH JOURNAL OF PHARMACOLOGY

T1270 Food Does Not Affect the Oral Bioavailability of Prucalopride

(2009) Vera J. Van de Velde et al.   GASTROENTEROLOGY

Safety assessment of prucalopride in elderly patients with constipation: a double-blind, placebo-controlled study

(2009) m. camilleri et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation - a 12-week, randomized, double-blind, placebo-controlled study

(2008) E. M. M. QUIGLEY et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Treatment of Chronic Constipation: Current Pharmacologic Approaches and Future Directions

(2008) Jan Tack et al.   Clinical Gastroenterology and Hepatology

934 Evaluation of the Efficacy, Safety and Tolerability of Prucalopride (Resolor®) Given Subcutaneously in Patients Undergoing Elective Partial Colectomies

(2008) Susan Galandiuk et al.   GASTROENTEROLOGY

Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives

(2008) J Tack et al.   GUT

A Placebo-Controlled Trial of Prucalopride for Severe Chronic Constipation

(2008) Michael Camilleri et al.   NEW ENGLAND JOURNAL OF MEDICINE